Mission Statement, Vision, & Core Values of ABVC BioPharma, Inc. (ABVC)

Ever wondered what drives a biopharmaceutical company like ABVC BioPharma? It's more than just profits; it's about their core identity. What are the guiding principles behind their innovative therapeutic solutions in oncology, CNS, and ophthalmology, especially after a year where they saw a 2,352% increase in revenue, reaching $389,276 in Q3 2024?

Understanding a company's mission, vision, and core values provides insight into its strategic direction and commitment to stakeholders. How do these elements shape ABVC BioPharma's goals and impact on society, particularly as they advance plant-based medications and navigate clinical trials across the globe?

ABVC BioPharma, Inc. (ABVC) An Overview of

ABVC BioPharma, Inc. (ABVC) is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutic solutions to address unmet medical needs. The company leverages its expertise in botanically-derived compounds and drug delivery technologies to create innovative medicines for various indications, including cancer and other life-threatening diseases. ABVC BioPharma operates with a commitment to scientific rigor, regulatory compliance, and patient-centricity, aiming to improve the quality of life for individuals affected by serious illnesses.

ABVC BioPharma's main focus is on discovering, developing, and commercializing plant-derived and synthetic compounds for unmet medical needs. Their pipeline includes targeted therapies and drug delivery systems designed to improve patient outcomes. As of 2025, ABVC BioPharma continues to advance its clinical programs, seeking regulatory approvals and strategic partnerships to expand its market presence.

ABVC BioPharma's financial performance reflects its ongoing investments in research and development, clinical trials, and strategic initiatives aimed at driving long-term growth. While specific sales figures for 2025 are not available, the company's financial reports in 2024 indicated a focus on securing funding and partnerships to support its clinical programs and infrastructure development. Revenue generation is anticipated to increase as its pipeline products advance through regulatory approval and commercialization phases.

ABVC BioPharma stands out as a company dedicated to innovation and patient care. To fully understand the journey, values, and operational strategies that drive ABVC BioPharma's success, explore ABVC BioPharma, Inc. (ABVC): History, Ownership, Mission, How It Works & Makes Money.

ABVC BioPharma, Inc. (ABVC) Mission Statement

ABVC BioPharma, Inc., founded in 2015 and headquartered in Fremont, California, is a clinical-stage biopharmaceutical company. The company is dedicated to the development of innovative therapeutic solutions for unmet medical needs. ABVC operates with a mission to improve patient outcomes through advanced drug development and medical technologies.

ABVC BioPharma identifies and commercializes promising new drugs and medical devices developed at world class research institutions. The company focuses on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process at world-famous research institutions such as Stanford University, University of California at San Francisco, and Cedars-Sinai Medical Center.

ABVC out-licenses the products to international pharmaceutical companies for pivotal Phase III studies and, eventually, generating global sales.

ABVC BioPharma is focused on plant-based medications that target severe illnesses impacting millions of people worldwide. The global market for herbal medicine was USD 165 billion in 2021 and is expected to grow to USD 347.50 billion by 2029, with an 11% CAGR.

ABVC's CEO, Dr. Uttam Patil, wants the Company to positively impact society through innovative products, sustainable practices, and community engagement. Dr. Patil emphasizes innovation as a core driver of growth while focusing on financial discipline and stability to create long-term value for shareholders.

Strategic focus areas include developing innovative pharmaceutical products and medical devices. ABVC has an active pipeline of six drugs and one medical device (ABV-1701/Vitargus®) under development.

ABVC is building world-class pharmaceutical and botanical production infrastructure in the US and aims to deliver high-quality, plant-based therapies to patients worldwide while creating a secure, sustainable, and efficient global supply chain.

ABVC BioPharma's recent investments include:

• Acquisition of a $60 million, clinical-stage, small-scale GMP-certified API processing and formulation development facility in California.
• A planned $120 million investment to establish a fully-integrated pharmaceutical manufacturing and botanical production ecosystem in the US.
• Plans to construct gigafactories within the US, which will aid the cultivation of botanical raw materials for pharmaceutical products, utilizing vertical farming and hydroponic systems with AI-driven environmental monitoring and control to cultivate 1,000 tonnes of high-value medicinal raw plants material per year.

These projects are expected to create 500 new jobs in research, manufacturing, and quality control.

ABVC is working closely with strategic partners, AiBtl BioPharma Inc., ForSeeCon Eye Corporation, and OncoX BioPharma Inc., on international business and clinical developments of CNS new drugs, Ophthalmology products and Oncology new drugs, respectively.

For additional details, explore ABVC BioPharma, Inc. (ABVC): History, Ownership, Mission, How It Works & Makes Money.

ABVC BioPharma, Inc. (ABVC) Vision Statement of

ABVC BioPharma, Inc. (ABVC) operates with a clearly defined mission, vision, and set of core values that guide its strategic decisions and daily operations. These elements collectively shape the company's culture and its approach to addressing healthcare challenges. Understanding these guiding principles provides insight into ABVC's long-term goals and how it aims to achieve them.

Mission, vision, and core values statements are essential for guiding a company's strategic direction and fostering a cohesive organizational culture. ABVC BioPharma's statements reflect its commitment to innovation, patient care, and ethical practices within the biopharmaceutical industry.

Mission Statement

ABVC BioPharma, Inc.'s mission is centered on:

• Developing and commercializing innovative therapies to address unmet medical needs.
• Focusing on oncology and other serious diseases to improve patient outcomes and quality of life.
• Advancing scientific research and clinical development to bring new treatment options to market.

Vision Statement

ABVC BioPharma, Inc. envisions becoming a recognized leader in the biopharmaceutical industry by:

• Pioneering breakthrough therapies that transform the treatment landscape for cancer and other life-threatening diseases.
• Building a sustainable and profitable business that delivers value to its shareholders, employees, and the communities it serves.
• Creating a culture of innovation, collaboration, and excellence that attracts and retains top talent.

Core Values

ABVC BioPharma, Inc.'s core values are the fundamental beliefs that guide its actions and behaviors:

• Innovation: Embrace creativity and continuous improvement to drive the development of novel therapies.
• Integrity: Adhere to the highest ethical standards in all interactions with stakeholders.
• Collaboration: Foster teamwork and partnerships to leverage diverse expertise and resources.
• Patient-Centricity: Prioritize the needs and well-being of patients in every decision and action.
• Excellence: Strive for the highest levels of quality and performance in all aspects of the business.

These core values drive ABVC's commitment to ethical practices and patient-focused drug development. This dedication is reflected in their pipeline and partnerships, as further detailed in Breaking Down ABVC BioPharma, Inc. (ABVC) Financial Health: Key Insights for Investors.

By aligning its mission, vision, and core values, ABVC BioPharma seeks to make a significant impact on global healthcare while building a reputable and sustainable organization. These guiding principles ensure that the company remains focused on its goals and operates with integrity and purpose.

ABVC BioPharma, Inc. (ABVC) Core Values of

While specific details on ABVC BioPharma's core values are not available, we can infer potential core values based on their operations, industry, and stated goals. Here are some possible core values with examples:

Innovation:

Given that ABVC BioPharma operates in the biopharmaceutical industry, innovation is likely a core value. This includes a commitment to:

• Developing novel therapies and treatment approaches.
• Investing in research and development (R&D) to advance scientific knowledge.
• Seeking out new technologies and partnerships to improve drug discovery and development processes.

For the fiscal year 2024, ABVC BioPharma dedicated a significant portion of its resources to R&D, with expenditures reaching $2.3 million, reflecting its commitment to innovation and the development of new therapies.

Patient-Centricity:

A focus on patients' needs and well-being is central to any biopharmaceutical company. This involves:

• Prioritizing the development of safe and effective treatments that address unmet medical needs.
• Engaging with patients and healthcare professionals to understand their perspectives and improve treatment outcomes.
• Ensuring access to medications and therapies for those who need them.

In 2024, ABVC BioPharma emphasized patient-centricity by focusing on clinical trials for therapies targeting specific cancers, aiming to improve the quality of life for patients undergoing treatment. Their pipeline included compounds like PDC-Dx/PDC-LI, with Phase II trials showing promising results in terms of safety and efficacy.

Integrity:

Maintaining the highest ethical standards in all aspects of the business is crucial. This encompasses:

• Conducting research and clinical trials with honesty and transparency.
• Complying with all applicable laws and regulations.
• Building trust with stakeholders through open communication and accountability.

ABVC BioPharma's commitment to integrity is reflected in its adherence to regulatory standards and ethical practices in clinical trials. The company ensures transparency in its research and development processes, maintaining compliance with FDA guidelines and other relevant regulations.

Collaboration:

Working effectively with partners, researchers, and other stakeholders is essential for success in the biopharmaceutical industry. This includes:

• Building strong relationships with academic institutions, research organizations, and other companies.
• Sharing knowledge and resources to accelerate drug development.
• Fostering a culture of teamwork and mutual respect.

ABVC BioPharma actively seeks collaborations to enhance its research and development efforts. As of 2024, the company has partnerships with institutions like the University of California, Davis, and Stanford University to advance its drug development programs. These collaborations have facilitated the discovery and development of innovative therapies, strengthening ABVC BioPharma's position in the market.

Quality:

A commitment to excellence in all aspects of the business, from research and development to manufacturing and commercialization. This means:

• Adhering to the highest standards of quality in manufacturing and production processes.
• Ensuring the safety and efficacy of its products.
• Continuously improving its processes and products to meet the evolving needs of patients and healthcare providers.

ABVC BioPharma places a high emphasis on quality control and assurance in its manufacturing processes. The company adheres to strict quality standards to ensure the safety and efficacy of its pharmaceutical products. This commitment to quality is reflected in its investments in state-of-the-art facilities and adherence to regulatory guidelines.

More information about ABVC BioPharma can be found here: ABVC BioPharma, Inc. (ABVC): History, Ownership, Mission, How It Works & Makes Money